BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Alavian SM. A shield against a monster: Hepatitis C in hemodialysis patients. World J Gastroenterol 2009; 15(6): 641-646 [PMID: 19222088 DOI: 10.3748/wjg.15.641]
URL: https://www.wjgnet.com/1007-9327/full/v15/i6/641.htm
Number Citing Articles
1
A. Slack, A. Yeoman, J. Wendon. Intensive Care Medicine2010;  doi: 10.1007/978-1-4419-5562-3_33
2
Marco Lombardi. Making the Point on Hepatitis B and C in Dialysis: Role of Patients' IsolationGiornale di Tecniche Nefrologiche e Dialitiche 2014; 26(4) doi: 10.5301/GTND.2014.12396
3
Nahid Ramezan Ghorbani, Shirin Djalalinia, Mitra Modirian, Zahra Esmaeili Abdar, Morteza Mansourian, Armita Mahdavi Gorabi, Hamid Asayesh, Hossein Ansari, Mehrdad Kazemzadeh Atoofi, Ramin Tajbakhsh, Mehdi Noroozi, Saeid Safiri, Mostafa Qorbani. Prevalence of hepatitis C infection in Iranian hemodialysis patients: An updated systematic review and meta-analysisJournal of Research in Medical Sciences 2017; 22(1) doi: 10.4103/jrms.JRMS_223_17
4
S Datta, N Goel, C Wattal. Utility of routine real time quantitative PCR monitoring of HCV infection in haemodialysis patientsIndian Journal of Medical Microbiology 2015; 33 doi: 10.4103/0255-0857.148832
5
Tatjana Vilibic-Cavlek, Jasmina Kucinar, Bernard Kaic, Maja Vilibic, Nenad Pandak, Ljubo Barbic, Vladimir Stevanovic, Jasmina Vranes. Epidemiology of hepatitis C in Croatia in the European contextWorld Journal of Gastroenterology 2015; 21(32): 9476-9493 doi: 10.3748/wjg.v21.i32.9476
6
Samantha Jingyun Koh, Wei Lun Liou, Sheryl Gan, Pei Yun Liu, Chee Chin Phang, Wan Cheng Chow, Rajneesh Kumar. Moving Toward Hepatitis C Elimination in Haemodialysis: HCV Antigen as a Practical Screening AlternativeCureus 2026;  doi: 10.7759/cureus.108567
7
Seyed-Moayed Alavian, Seyed-Vahid Tabatabaei, Nastaran Mahboobi. Epidemiology and risk factors of HCV infection among hemodialysis patients in countries of the Eastern Mediterranean Regional Office of WHO (EMRO): a quantitative review of literatureJournal of Public Health 2011; 19(2) doi: 10.1007/s10389-010-0366-2
8
Ignatius Y. S. Tang, Natasha Walzer, Nidhi Aggarwal, Ivo Tzvetanov, Scott Cotler, Enrico Benedetti. Management of the Kidney Transplant Patient with Chronic Hepatitis C InfectionInternational Journal of Nephrology 2011; 2011 doi: 10.4061/2011/245823
9
Meryem Güvenir, Emrah Guler, Deren Oygar, Ahmet Behlul, Kaya Suer. Evaluating the Prevalence of HBV, HCV, and HIV in Hemodialysis Patients in North CyprusHepatitis Monthly 2019; (In Press) doi: 10.5812/hepatmon.84699
10
A. Slack, A. Yeoman, J. Wendon. Yearbook of Intensive Care and Emergency Medicine 2010Yearbook of Intensive Care and Emergency Medicine 2010; 2010 doi: 10.1007/978-3-642-10286-8_33
11
Hao-Hsi Kao, Kuo-Su Chen, Chih-Lang Lin, Jia-Jang Chang, Chien-Hung Lee. Utilization of Signal-to-Cutoff Ratio of Hepatitis C Virus Antibody Assay in Predicting HCV Viremia among Hemodialysis PatientsNephron 2015; 130(2) doi: 10.1159/000430988
12
Yu-Ming Wang, Mao-Rong Wang, Chang-Lun He, Yue Wang, Yue-Cheng Yu. Management of hepatitis C virus infection in hemodialysis patientsWorld Journal of Hepatology 2014; 6(6): 419-425 doi: 10.4254/wjh.v6.i6.419
13
Rising burden of Hepatitis C Virus in hemodialysis patientsVirology Journal 2011; 8(1) doi: 10.1186/1743-422X-8-438
14
Seyed Moayed Alavian, Kamran Bagheri Lankarani, Ala I. Sharara. Treatment of Chronic HCV in Special Populations: Thalassemia, Hemophilia, and Hemodialysis PatientsCurrent Hepatitis Reports 2012; 11(4) doi: 10.1007/s11901-012-0147-1
15
Marzieh Jamalidoust, Maryam Eskandari, Mazyar Ziyaeyan. Prevalence of Hepatitis C Infection and its Genotypes in Suspected Hemodialysis Patients, Southwest of IranJundishapur Journal of Microbiology 2021; 14(11) doi: 10.5812/jjm.118591
16
Dimie Aruna, Abubakar Adereti, Easley A. Munir. Prevalence of hepatitis C virus infection among hemodialysis patients: cohort studyAmerican Journal of BioMedicine 2023; 11(1) doi: 10.18081/2333-5106/2023.11/36
17
Mary Anne Bobinski. Health Care–Associated Hepatitis B and C Viruses: Legal AspectsClinics in Liver Disease 2010; 14(1) doi: 10.1016/j.cld.2009.11.002
18
Seyyed Moayed Alavian. Seronegative anti‐hepatitis C virus antibody in hemodialysis patientsHemodialysis International 2013; 17(2) doi: 10.1111/j.1542-4758.2012.00738.x
19
Sohail Akhtar, Jamal Abdul Nasir, Muhammad Usman, Aqsa Sarwar, Rizwana Majeed, Baki Billah, Ming-Lung Yu. The prevalence of hepatitis C virus in hemodialysis patients in Pakistan: A systematic review and meta-analysisPLOS ONE 2020; 15(5) doi: 10.1371/journal.pone.0232931
20
Seyed Moayed Alavian. An Unbelievable Fact on “Dialysis Centers Without Hepatitis C Infection”Nephro-Urology Monthly 2014; 6(2) doi: 10.5812/numonthly.17998
21
Soheil Ashkani-Esfahani, Seyed Moayed Alavian, Mohammad Salehi-Marzijarani. Prevalence of hepatitis C virus infection among hemodialysis patients in the Middle-East: A systematic review and meta-analysisWorld Journal of Gastroenterology 2017; 23(1): 151-166 doi: 10.3748/wjg.v23.i1.151
22
Seyed Moayed Alavian. Occult Hepatitis B and Hemodialysis Patients Need Increased Precautions With the Interpretation of ResultsTherapeutic Apheresis and Dialysis 2010; 14(6) doi: 10.1111/j.1744-9987.2010.00878.x